Safety & Efficacy Of Pirfenidone For Ipf - Part 1

Safety & Efficacy of Pirfenidone for IPF - Part 1

Safety and Management of Side Effects of Pirfenidone and Nintedanib | Wendi Mason, MSN

Pulmonary Fibrosis Foundation

Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults

American Thoracic Society

Pharmacologic Therapy | Charlene Fell, MD, MSc

Pulmonary Fibrosis Foundation

Safety and Efficacy of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis: Pirfenidone

Demystifying Medicine McMaster

Idiopathic pulmonary fibrosis: Medical research

Demystifying Medicine McMaster

Discovering New Drugs for IPF

The France Foundation

Overview of Pirfenidone and Nintedanib | Joyce Lee, MD

Pulmonary Fibrosis Foundation

IPFsym®, a platform to support the development of effective treatments for IPF patients

Simulations Plus, Inc.

Impact Of Patient Education And Follow Up With Pirfenidone In Patients With IPF

The France Foundation

IPF Treatment: Starting on Pirfenidone

PlatformQ Health

INPULSIS-ON: Nintedanib shows manageable long-term safety for IPF

MDedge: news and insights for busy physicians

The Importance of Early Referral and Treatment for IPF

The France Foundation

Dr Steven Nathan Discusses the 2 Newly Approved Drugs to Treat IPF

Pirfenidone and Nintedanib Tips for Treating Patients with Idiopathic Pulmonary

Bolton Pulmonary Fibrosis Support Group

Mechanism of Action of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis (IPF)

Esbriet (Pirfenidone) Medication Online at Discount Price | Overview

Consistent efficacy and safety of OFEV: regardless of background immunosuppressant use